The California Department of Fish and Wildlife (CDFW) recently published a report summarizing its management and conservation activities for gray wolves (Canis lupus) over the past 10 years. “Ten ...

If Trump actually fires Powell, expect chaos. That’s the blunt warning from Wall Street analysts, legal professionals, and ...

Former deputy Treasury Secretary Roger Altman said he did not think Jerome Powell would agree to leave if the president asked ...

Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

Fintel reports that on July 15, 2025, Wolfe Research downgraded their outlook for Realty Income (NYSE:O) from Outperform to ...

Fintel reports that on July 14, 2025, Wolfe Research downgraded their outlook for HF Sinclair (NYSE:DINO) from Peer Perform ...

Overall, Wolfe favors a mix of growth and value as the second half of 2025 begins. Related articles Wolfe Research refreshes high-conviction ideas heading into H2 ...

Science Trump Is Gutting LGBTQ+ Research. It’s Going to Cost Us All. Everyone’s health is at stake.

Wolfe Research bumped its price target on Samsara (NYSE: IOT) to $45 from $41 in early June, keeping its Outperform rating in place.

Wolfe Research’s analysts highlighted that the company could see $1.8 billion in tax savings in 2025 alone. This is a 30% free cash flow (FCF) boost, potentially doubling FCF per share by 2027.

N.I.H. Memo Pauses Cancellations of Medical Research Grants The directive, in a memo issued Tuesday, came after two court rulings that questioned the Trump administration’s swift cuts to funding.